The trials and tribulations of IL-5, eosinophils, and allergic asthma

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 4, 2001, Pages 503-508

  O’byrne, Paul M ^a   Inman, Mark D ^a   Parameswaran, Krishnan ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Airway hyperresponsiveness; Allergen; Asthma; Eosinophils; Interleukin 5; Late asthmatic responses

Indexed keywords

ALLERGEN; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; MEPOLIZUMAB; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ARTICLE; ATOPY; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFECT; EOSINOPHIL; EOSINOPHILIA; HUMAN; INFLAMMATION; INHALATION; LUNG LAVAGE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 0034780052     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.119149     Document Type: Article

References (45)

1. The pathology of bronchial asthma
2. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma
3. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5)
4. Interleukin-5: An eosinophil growth and activation factor
5. Human eosinophil hematopdiesis studied in vitro by means of murine eosinophil differentiation factor (IL-5): Production of functionally active eosinophils from normal human bone marrow
6. Recombinant human interleukin 5 is a selective activator of human eosinophil function
7. Recombinant human interleukin 5 is a selective eosinophil chemoattractant
8. The biological role of interleukin 5
9. Anti-interleukin-5 strategies as a potential treatment for asthma
10. Combined antagonist of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics
11. Late asthmatic responses
12. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation
13. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge in atopic asthmatics
14. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor MRNA at sites of allergic inflammation
15. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low dose allergen challenge in atopic asthmatics
16. Increased levels of IL-5 positive peripheral blood eosinophils and lymphocytes in mild asthmatics after allergen inhalation provocation
17. Increased levels of CD34 hemopoietic progenitor cells in atopic subjects
18. Blood eosinophils, basophils and progenitors during asthma exacerbations and resolution
19. Basophilic cell progenitors, nasal metachromatic cells and peripheral blood basophils in ragweed-allergic patients
20. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors
21. Bone marrow inflammatory progenitor cells after allergen inhalation in asthmatic subjects
22. Allergen-induced increases in IL-5 a subunit expression on bone marrow derived CD34+ cells from asthmatic subjects: A novel marker of progenitor cell commitment towards eosinophil differentiation
23. Eosinopbilia in mice expressing interleukin 5
24. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
25. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
26. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma
27. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
28. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice
29. Interleukin-13: Central mediator of allergic asthma
30. Requirement for IL-13 independently of IL-4 in experimental asthma
31. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness
32. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma
33. Interleukin-5 and eosthophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice
34. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma
35. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
36. The allergen-induced airway hyperresponsiveness in a human-mouse chimera model of asthma is T cell and IL-4 and IL-5 dependent
37. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
38. Effect of indomethacin on allergen-induced asthmatic responses
39. Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine
40. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation
41. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs
42. Reproducibility of allergen-induced early and late asthmatic responses
43. Repeatability of allergen-induced airway inflammation
44. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: Results of a factor analysis
45. Predictors of late asthmatic response. Logistic regression and classification tree analyses